Dr. Nicole Haynes
Honorary
The Sir Peter Maccallum Department of Oncology
34 Scholarly works
7 Projects
HIGHLIGHTS
2021
Journal article
Molecular and genomic characterisation of a panel of human anal cancer cell lines
DOI: 10.1038/s41419-021-04141-52021
Journal article
CDK4/6 Inhibition Promotes Antitumor Immunity through the Induction of T-cell Memory
DOI: 10.1158/2159-8290.CD-20-15542021
Journal article
Regulatory T Cells Shape the Differential Impact of Radiation Dose-Fractionation Schedules on Host Innate and Adaptive Antitumor Immune Defenses
DOI: 10.1016/j.ijrobp.2021.05.0142021
Journal article
Single-Fraction vs Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases (SAFRON II) The Trans Tasman Radiation Oncology Group 13.01 Phase 2 Randomized Clinical Trial
DOI: 10.1001/jamaoncol.2021.29392021
Research Grant
ACRF Radiation Immuno-oncology Program
2017
Research Grant
COMBINATION OF RADIONUCLIDE 177LU-PSMA THERAPY WITH PEMBROLIZUMAB IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC)
2016
Research Grant
THE COMBINATION OF CDK4 AND MAPK/ERK PATHWAY INHIBITOR THERAPY IN MELANOMA: DEFINING MELANOMA CELL INTRINSIC AND IMMUNE MEDIATED RESPONSES
RECENT SCHOLARLY WORKS
2021
Journal article
Combined BRAF, MEK, and CDK4/6 Inhibition Depletes Intratumoral Immune-Potentiating Myeloid Populations in Melanoma
DOI: 10.1158/2326-6066.CIR-20-04012020
Conference Proceedings
OC-0080: Radiation therapy increases tumor vulnerability to natural killer cell-mediated control
DOI: 10.1016/s0167-8140(21)00106-72020
Journal article
Abscopal Regressions of Lymphoma After Involved-Site Radiation Therapy Confirmed by Positron Emission Tomography
DOI: 10.1016/j.ijrobp.2020.02.6362019
Conference Proceedings
Development of small molecule STING agonists that can evoke host anti-cancer immune defences following local or systemic delivery
2019
Journal article
A Functional Immune System Is Required for the Systemic Genotoxic Effects of Localized Irradiation
DOI: 10.1016/j.ijrobp.2018.11.0662019
Journal article
A novel immunogenic mouse model of melanoma for the preclinical assessment of combination targeted and immune-based therapy
DOI: 10.1038/s41598-018-37883-y
RECENT PROJECTS
2016
Research Grant
HARNESSING THE IMMUNE SYSTEM WITH EPIGENETIC THERAPIES TO TREAT HER2+ BREAST CANCER
2013
Research Grant
BUILDING IMMUNITY TO BREAST CANCER WITH RADIO-IMMUNOTHERAPY COMBINATIONS